Zymosense Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $400K

  • Investors
  • 6

Zymosense General Information

Description

Developer of single-walled carbon nanotubes and nanosensor technologies designed for enzyme activity measurement. The company's products include chirally enriched nanotubes, functionalized nanosensors, and a portable enzyme activity analysis kit, enabling companies to conduct rapid, label-free, real-time enzyme activity analysis for laboratory and field applications.

Contact Information

Website
www.zymosense.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 2501 North Loop Drive
  • Suite 1010
  • Ames, IA 50010
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Services
Biotechnology
Vertical(s)
Nanotechnology, Life Sciences
Corporate Office
  • 2501 North Loop Drive
  • Suite 1010
  • Ames, IA 50010
  • United States

Zymosense Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zymosense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 30-Sep-2024 $400K Completed Generating Revenue
6. Grant 28-Feb-2023 Completed Generating Revenue
5. Grant 23-Jul-2022 Completed Generating Revenue
4. Accelerator/Incubator 29-Jun-2022 Completed Generating Revenue
3. Grant 31-Dec-2021 Completed Generating Revenue
2. Grant 01-Aug-2021 $500K Completed Generating Revenue
1. Accelerator/Incubator 22-Jun-2021 Completed Generating Revenue
To view Zymosense’s complete valuation and funding history, request access »

Zymosense Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zymosense Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
US National Science Foundation Accelerator/Incubator
Iowa Economic Development Authority Government
Iowa G2M Accelerator/Incubator
U.S. Department of Commerce Government
National Institute of Standards and Technology Government
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Zymosense FAQs

  • When was Zymosense founded?

    Zymosense was founded in 2021.

  • Where is Zymosense headquartered?

    Zymosense is headquartered in Ames, IA.

  • What is the size of Zymosense?

    Zymosense has 6 total employees.

  • What industry is Zymosense in?

    Zymosense’s primary industry is Discovery Tools (Healthcare).

  • Is Zymosense a private or public company?

    Zymosense is a Private company.

  • What is Zymosense’s current revenue?

    The current revenue for Zymosense is .

  • Who are Zymosense’s investors?

    US National Science Foundation, Iowa Economic Development Authority, Iowa G2M, U.S. Department of Commerce, and National Institute of Standards and Technology are 5 of 6 investors who have invested in Zymosense.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process